Abstract
The incidence of hepatocellular carcinoma continues to increase worldwide, representing one of the premier causes of cancer-related deaths. It is closely related to liver fibrosis and cirrhosis (and their underlying etiologies), thus making its treatment a challenge, as one has to simultaneously manage both the liver disease, as well as the malignancy. Although there are a variety of different therapies proposed, the two main ones that can actually lead to a therapeutic result, are surgical resection and orthotopic liver transplantation. However, the challenge remains in terms of early diagnosis of the disease, identifying the steps that lead to its progression and choosing the best treatment for each patient. Regarding this latter comment, it has been determined that not all cancers are the same, in the sense that their molecular make-up and alterations are what dictate their specific behavior and aggressiveness; which would be helpful to know if the goal is to choose a patient- and tumor-oriented individualized approach, that will yield better results. Critical in this effort has been and continues to be the role of microRNA, which appears to play a central role in the progression, diagnosis and management of hepatocellular carcinoma. This paper will attempt to clarify the role of microRNA in these areas and provide a window to the future.
Keywords: Biomarkers, hepatocellular carcinoma, microRNA, orthotopic liver transplantation, surgical resection, therapy.
MicroRNA
Title:Role of MicroRNA in the Diagnosis and Therapy of Hepatocellular Carcinoma: A New Frontier
Volume: 3 Issue: 3
Author(s): Georgios Tsoulfas
Affiliation:
Keywords: Biomarkers, hepatocellular carcinoma, microRNA, orthotopic liver transplantation, surgical resection, therapy.
Abstract: The incidence of hepatocellular carcinoma continues to increase worldwide, representing one of the premier causes of cancer-related deaths. It is closely related to liver fibrosis and cirrhosis (and their underlying etiologies), thus making its treatment a challenge, as one has to simultaneously manage both the liver disease, as well as the malignancy. Although there are a variety of different therapies proposed, the two main ones that can actually lead to a therapeutic result, are surgical resection and orthotopic liver transplantation. However, the challenge remains in terms of early diagnosis of the disease, identifying the steps that lead to its progression and choosing the best treatment for each patient. Regarding this latter comment, it has been determined that not all cancers are the same, in the sense that their molecular make-up and alterations are what dictate their specific behavior and aggressiveness; which would be helpful to know if the goal is to choose a patient- and tumor-oriented individualized approach, that will yield better results. Critical in this effort has been and continues to be the role of microRNA, which appears to play a central role in the progression, diagnosis and management of hepatocellular carcinoma. This paper will attempt to clarify the role of microRNA in these areas and provide a window to the future.
Export Options
About this article
Cite this article as:
Tsoulfas Georgios, Role of MicroRNA in the Diagnosis and Therapy of Hepatocellular Carcinoma: A New Frontier, MicroRNA 2014; 3 (3) . https://dx.doi.org/10.2174/2211536604999141222225112
DOI https://dx.doi.org/10.2174/2211536604999141222225112 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
Call for Papers in Thematic Issues
Modulatory Roles of Non-coding RNAs in cancer therapy
This thematic issue aims to elucidate the most recent research on ncRNAs in CRCs and discuss the importance and difficulties that may arise in applying this tool on a regular clinical basis.read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aldehyde Dehydrogenase as a Marker for Stem Cells
Current Stem Cell Research & Therapy The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
Current Medicinal Chemistry The Molecular Basis of Notch Signaling Regulation: A Complex Simplicity
Current Molecular Medicine Population Based Helicobacter pylori Screening and Eradication: Advances Versus Side Effects
Current Pharmaceutical Design β-lactam Structured, 4-(4-(Methylsulfonyl)phenyl)-1-pentyl-3-phenoxyazetidin-2-one: Selectively Targets Cancerous B Lymphocyte Mitochondria
Anti-Cancer Agents in Medicinal Chemistry Experimental Strategies in Autoimmunity: Antagonists of Cytokines and their Receptors, Nanocarriers, Inhibitors of Immunoproteasome, Leukocyte Migration and Protein Kinases
Current Pharmaceutical Design The Impact of Molecularly Targeted Therapies Upon the Understanding of Leukemogenesis and the Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
Current Stem Cell Research & Therapy Therapeutic Strategy of Advanced Hepatocellular Carcinoma by Using Combined Intra-Arterial Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Editorial (Thematic Issue: Antitarget Therapies: New Frontiers in the Treatment of Cancer)
Anti-Cancer Agents in Medicinal Chemistry Gene Therapy for Wiskott-Aldrich Syndrome
Current Gene Therapy Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
Current Topics in Medicinal Chemistry Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer
Current Chemical Biology Studies on Efficacy of a Novel 177Lu-Labeled Porphyrin Derivative in Regression of Tumors in Mouse Model
Current Radiopharmaceuticals Synthesis and Antitumoral Evaluation of 7-chloro-4-quinolinylhydrazones Derivatives
Medicinal Chemistry Meet Our Editors
Medicinal Chemistry Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Curcumin: Structure-Activity Relationship Towards its Role as a Versatile Multi-Targeted Therapeutics
Mini-Reviews in Organic Chemistry New N’-Arylidene-2-[(4-Nitrophenyl)Piperazın-1-yl]Acetohydrazide Derivatives: Synthesis and Anticancer Activity Investigation
Letters in Drug Design & Discovery Aptamers as Targeting Delivery Devices or Anti-cancer Drugs for Fighting Tumors
Current Drug Metabolism Epidemiology and Management of Infectious Complications in Contemporary Management of Chronic Leukemias
Infectious Disorders - Drug Targets